← Open Payments lookup

DEBRA HUDSON: Open Payments

NPI 1962642355 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,808 in 80 payments from 16 companies in 2025. Trend: 2023 $1,432 · 2024 $1,292 · 2025 $1,808

Food & beverage: $1,808
CompanyPaymentsAmount
ABBVIE INC.22$601
Janssen Biotech, Inc.9$205
Aimmune Therapeutics, Inc.11$196
Takeda Pharmaceuticals U.S.A., Inc.8$158
Phathom Pharmaceuticals, Inc.6$132
GENZYME CORPORATION4$96
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
Madrigal Pharmaceuticals2$67
Celltrion USA Inc.3$64
Regeneron Healthcare Solutions, Inc.2$45

Products named: TREMFYA, SKYRIZI, RINVOQ, VOQUEZNA, ENTYVIO, ZENPEP, DUPIXENT, LINZESS.

Industry payments across TX — which companies pay providers there.